Is DCTH or NVCT more profitable?

DCTH runs the higher net margin — DCTH at 0.56% versus NVCT at 0.00%.

Delcath Systems, Inc. (DCTH) vs Nuvectis Pharma, Inc. (NVCT)

A side-by-side comparison of Delcath Systems, Inc. and Nuvectis Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DCTH

Delcath Systems, Inc.

$539M

$15.60HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT

NVCT

Nuvectis Pharma, Inc.

$545M

$20.55HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT

Total return — DCTH vs NVCT

growth of $100 · dividends reinvested · last 5y

DCTH +116.2% (+16.7%/yr)NVCT +558.2% (+45.8%/yr)NVCT compounded faster over this window

DCTH NVCT

DCTH vs NVCT: by the numbers

•NVCT is the larger company ($545M vs $539M market cap).
•DCTH is profitable (0.56% net margin) while NVCT runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	DCTH	NVCT
P/E ratio	1200.17	N/A
P/S ratio	5.64	N/A
P/B ratio	4.45	60.03
FCF yield	3.25%	N/A

Profitability

Metric	DCTH	NVCT
Gross margin	87.05%	0.00%
Operating margin	-1.90%	0.00%
Net margin	0.56%	0.00%
ROE	0.44%	-306.61%
ROIC	-0.81%	-317.86%

Growth (annualized)

Metric	DCTH	NVCT
Revenue CAGR (5Y)	118.96%	N/A
Total return CAGR (5Y)	10.90%	N/A

Frequently asked

Is DCTH or NVCT more profitable?: DCTH runs the higher net margin — DCTH at 0.56% versus NVCT at 0.00%.

Go deeper

Full DCTH analysis Full NVCT analysis Interactive comparison tool

Dig into the metrics

Delcath Systems P/E ratio Delcath Systems ROE Nuvectis Pharma ROE Delcath Systems operating margin Nuvectis Pharma operating margin Delcath Systems revenue growth Nuvectis Pharma revenue growth Delcath Systems free cash flow Nuvectis Pharma free cash flow

Delcath Systems & Nuvectis Pharma appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.